Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Short Interest Update

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) was the recipient of a significant drop in short interest during the month of December. As of December 31st, there was short interest totalling 10,400 shares, a drop of 62.6% from the December 15th total of 27,800 shares. Based on an average daily volume of 273,300 shares, the short-interest ratio is presently 0.0 days.

Biodexa Pharmaceuticals Trading Up 2.2 %

Shares of BDRX stock traded up $0.10 on Tuesday, hitting $4.40. The stock had a trading volume of 1,221 shares, compared to its average volume of 14,315. The firm has a 50 day moving average of $4.60. Biodexa Pharmaceuticals has a 1 year low of $3.50 and a 1 year high of $74.00.

Biodexa Pharmaceuticals Company Profile

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.